HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The pharmacological effect of betapressin in hypertension].

Abstract
The work analyses the results of treating 20 hypertensive patients with (stage I-II) with betapressin. The drug is shown to be active in causing a significant decrease of systolic and mean arterial pressure. Its hypotensive effect is associated with essential decrease of peripheral vascular resistance. This circumstance, as well as acceleration of the heart rhythm, leads to increase of the cardiac output. Betapressin is recommended for monotherapy of patients suffering from stages I-II hypertension with eu- and hypokinetic types of hemodynamics.
AuthorsR M Zaslavskaia, K Zh Akhmetov, V A Gol'denberg, G V Lilitsa
JournalEksperimental'naia i klinicheskaia farmakologiia (Eksp Klin Farmakol) 1996 Nov-Dec Vol. 59 Issue 6 Pg. 23-5 ISSN: 0869-2092 [Print] Russia (Federation)
Vernacular TitleFarmakologicheskiĭ éffekt betapressina pri gipertonicheskoĭ bolezni.
PMID9181866 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antihypertensive Agents
  • Penbutolol
Topics
  • Adult
  • Analysis of Variance
  • Antihypertensive Agents (administration & dosage, pharmacology)
  • Chronic Disease
  • Drug Evaluation
  • Female
  • Hemodynamics (drug effects)
  • Humans
  • Hypertension (drug therapy, physiopathology)
  • Male
  • Middle Aged
  • Penbutolol (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: